Objectives Non-tuberculous mycobacteria (NTM) frequently colonize the airways of patients
with bronchiectasis; however, there has been limited research into airway microbiota …

Background The incidence of nontuberculous mycobacterial pulmonary disease (PNTM) is
rising, but available diagnostics and treatments have limitations. The lung microbiota plays …

Understanding the dynamics of lung microbiota in tuberculosis patients, especially those
who cannot be confirmed bacteriologically in clinical practice, is imperative for accurate …

This study aimed to investigate the disparities between metagenomic next-generation
sequencing (mNGS) and conventional culture results in patients with bronchiectasis …

Background Lower respiratory tract infections represent prevalent ailments. Nonetheless,
current comprehension of the microbial ecosystems within the lower respiratory tract …

This study used metagenomic next-generation sequencing (mNGS) technology to explore
the changes of the microbial characteristics in the lower respiratory tract in patients with …

Background: The incidence of nontuberculous mycobacterial pulmonary disease (PNTM) is
rising, but the available treatments have limitations. Currently, the understanding of the …

The microbiota plays an important role in human health and disease development. The lung
microbiota profile in pulmonary tuberculosis (TB) patients and the effects of anti-TB treatment …

Objectives Predicting progression of nontuberculous mycobacterial lung disease (NTM-LD)
remains challenging. This study evaluated whether sputum bacterial microbiome diversity …

Rationale: Although airway microbiota composition correlates with clinical measures in non–
cystic fibrosis bronchiectasis, these data are unlikely to provide useful prognostic information …